weight loss microdosing tirzepatide & GLP-1 Treatments The rumors are true… GLP-1s

Protein is also more satiating than carbohydrates or fat, which can support steady energy throughout the day

One working hypothesis is that modulation of the gut microbes by the antimicrobial agent berberine could alter the composition of bacteria in the gut and lead to these observed effects

To view or add a comment, sign in Obesity treatment just got a major upgrade

Need for a standardized translational drug development platform: lessons learned from the repurposing of drugs for COVID-19

At our clinic, you will be prescribed these medications under direct physician supervision

For example, a patient with type 2 diabetes on GLP-1 scheduled for hip replacement may continue the agent until 1 to 2 weeks pre-op if weight loss is modest, but stop earlier if gastroparesis or severe nausea is present